MDxHealth (MDXH) Return on Sales (2021 - 2026)

MDxHealth has disclosed Return on Sales across 6 years of filings, most recently posting 0.0% for Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at MDxHealth, up from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 29.7% in Q2 2022 to a low of 0.01% in Q1 2022.
• The 5-year median for Return on Sales is 0.0% (2024), against an average of 1.74%.
• Peak annual rise in Return on Sales reached 1 bps in 2023, while the deepest fall reached 2970 bps in 2023.
• MDxHealth's Return on Sales stood at 0.01% in 2022, then soared by 42 bps to 0.01% in 2023, then soared by 51 bps to 0.0% in 2024, then sank by 50 bps to 0.0% in 2025, then gained by 21 bps to 0.0% in 2026.
• The last three Return on Sales figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.